ACT-293987 in Pulmonary Arterial Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 709 participants.
Also called NCT01112306
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 709 participants
- Sponsor
- Registry
-
NCT01112306 -
2009-014992-31
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, France, Germany, Greece, Hungary, India, Ireland, Israel, Malaysia, Mexico, Netherlands, Peru, Poland, Romania, Russia, Serbia, Singapore, Slovakia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Türkiye, Ukraine, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01112306. Allocation not applicable; no masking; primary purpose treatment. Start 2010-07-07 (actual); primary completion 2021-08-26 (actual). Results posted on 2022-09-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ACT-293987 in Pulmonary Arterial Hypertension
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Drug)
- ACT-293987
- Lead sponsor
- Actelion
Record details
- Record id
cardio:ct-nct01112306- Content hash
fd49496460f78231fadee783aeb83f28867b06f7205b70632f9173ba3c64a836